NEW YORK, Jan. 6, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces that it has acted on behalf of the purchasers of BioLineRx Ltd. filed a class action lawsuit. BLRX between February 23, 2021 and September 19, 2022, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court by March 6, 2023 at the latest.

SO WHAT: If you have purchased BioLine securities, you may be entitled to compensation without payment of out-of-pocket expenses or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To participate in the BioLine Class Action, go to https://rosenlegal.com/submit-form/?case_id=8781 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email pkim@rosenlegal.com or cases@rosenlegal.com for information about the Class Action. A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court by March 6, 2023 at the latest. A lead plaintiff is a representative party acting on behalf of other group members in conducting the litigation.

WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Many of these firms do not conduct securities class action lawsuits. Be wise in choosing a lawyer. The Rosen Law Firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivatives litigation. Rosen Law Firm has achieved the largest-ever settlement of a securities class action lawsuit against a Chinese company. Rosen Law Firm was ranked #1 in 2017 by ISS Securities Class Action Services for the number of securities class action settlements. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured over $438…